Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic

Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.

From Siemens Healthineers Point of Care Diagnostics 24 Apr 2020

Anti-vaccine activists latch onto coronavirus to bolster their movement

While most of the world hungers for a vaccine to put an end to the death and economic destruction wrought by COVID-19, some anti-vaccine groups are joining with anti-lockdown protesters to challenge restrictions aimed at protecting public health.

24 Apr 2020

Vaping, opioid addiction accelerate coronavirus risks, says NIDA director

In 2018, opioid overdoses claimed about 47,000 American lives. Last year, federal authorities reported that 5.4 million middle and high school students vaped. And just two months ago, about 2,800 cases of vaping-associated lung injuries resulted in hospitalizations; 68 people died.

24 Apr 2020

Seniors with COVID-19 show unusual symptoms, doctors say

Older adults with COVID-19, the illness caused by the coronavirus, have several "atypical" symptoms, complicating efforts to ensure they get timely and appropriate treatment, according to physicians.

24 Apr 2020

Born into a pandemic: Virus complicates births for moms and babies

Mallory Pease's contractions grew stronger as her husband, Mitchell, drove her to Oaklawn Hospital in Marshall, Michigan, to give birth to their second child. It had been a routine pregnancy, but she told her doctor she'd recently developed a sore throat, aches, coughing and shortness of breath — symptoms her provider knew could indicate COVID-19.

24 Apr 2020

Goblet cells in the human nasal passage may play key role in enabling COVID-19 infections

Two significant international studies involving hundreds of scientists, including a human geneticist at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that specific cells in the human nasal passage shaped like a champagne glass, known as goblet cells, may play a significant role in enabling COVID-19 infections.

24 Apr 2020

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Before being halted due to the COVID-19 pandemic, a relentless vaccination campaign had nearly succeeded in eradicating polio from the world.

24 Apr 2020

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates.

24 Apr 2020

COVID-19 triggers adoption of telemedicine approaches to delivering neurology care

As COVID-19-related social isolation and distancing make it increasingly difficult for people with neurological conditions to access routine medical care, the crisis is transforming the way care is being delivered to these vulnerable individuals, according to neurology service providers.

24 Apr 2020

Scientists are developing synthetic COVID-19 antibody to treat sick patients

A team of researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with GenScript, is developing a synthetic antibody to SARS-CoV-2, the virus that causes coronavirus disease (COVID-19). This antibody is intended to block the virus from entering human lung cells, and would be another potential treatment option for COVID-19.

24 Apr 2020

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

NEC Corporation today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population.

24 Apr 2020

Sygnature Discovery loans key equipment to support UK Government’s COVID-19 testing strategy

Sygnature Group is supporting the Government’s COVID-19 testing strategy with the loan of a key piece of equipment. The machine, a Tecan Freedom EVO 100, will be used to help automate and accelerate the analysis of samples at the first of the UK Government’s new Lighthouse Labs in Milton Keynes.

24 Apr 2020

UK engineers develop low-cost Field Ventilator to treat COVID-19 patients in poorer countries

A UK team of academic and industrial engineers, manufacturers and clinicians have developed a potentially life-saving ventilator to treat coronavirus patients in poor and remote parts of the world.

24 Apr 2020

AEM and Wiley offer full access to facilitate rapid dissemination of COVID-19 findings

To facilitate the rapid dissemination of COVID-19 findings, Academic Emergency Medicine (AEM) journal, in collaboration with Wiley Publishing, is fast-tracking submissions related to COVID-19 and making the latest, most relevant research available in an easy-to-navigate, freely accessible online collection of accepted and citable articles.

24 Apr 2020

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

Researchers in the Center for Translational Medicine at the University of Montana have been awarded $2.5 million in funding from the National Institutes of Health to identify and advance a COVID-19 vaccine candidate.

24 Apr 2020

UAB to join international effort to test drugs for COVID-19

The University of Alabama at Birmingham will join an international effort coordinated by Scripps Research to test drugs for COVID-19.

24 Apr 2020

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

Herd immunity is a form of indirect protection against infectious diseases where a population develops sufficient immunity to a disease that that infection cannot spread within the group. A population can reach herd immunity if a large proportion has been exposed to the virus. Now, Sweden resisted total lockdown measures, unlike its neighboring countries, while experts believe herd immunity will be achieved in Stockholm within weeks.

24 Apr 2020

First COVID-19-related clinical trial to start in Germany

German regulators have approved the first clinical trial of a coronavirus vaccine. Developed by BioNTech SE, an immunotherapy company, and Pfizer, a pharmaceutical company, the potential coronavirus vaccine has completed pre-clinical studies in Germany.

24 Apr 2020

Fraunhofer SCAI is opening a new knowledge space with information and analysis tools on COVID-19

With the new website "covid19-knowledgespace.de", Fraunhofer SCAI - together with Fraunhofer IME, Fraunhofer IAIS, the Information Center for Life Sciences ZBMED and other research partners - is opening a new kind of knowledge space with analysis tools and information on COVID-19.

24 Apr 2020

Research looks at best ways to tackle coronavirus crisis

A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.

24 Apr 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test to aid in the COVID-19 pandemic

Anti-vaccine activists latch onto coronavirus to bolster their movement

Vaping, opioid addiction accelerate coronavirus risks, says NIDA director

Seniors with COVID-19 show unusual symptoms, doctors say

Born into a pandemic: Virus complicates births for moms and babies

Goblet cells in the human nasal passage may play key role in enabling COVID-19 infections

Researchers report promising Phase 1 results for first oral polio vaccine in 50 years

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

COVID-19 triggers adoption of telemedicine approaches to delivering neurology care

Scientists are developing synthetic COVID-19 antibody to treat sick patients

NEC leverages its AI prediction platforms to design blueprints for SARS-CoV-2 vaccines

Sygnature Discovery loans key equipment to support UK Government’s COVID-19 testing strategy

UK engineers develop low-cost Field Ventilator to treat COVID-19 patients in poorer countries

AEM and Wiley offer full access to facilitate rapid dissemination of COVID-19 findings

UM researchers awarded $2.5 million to develop COVID-19 vaccine candidate

UAB to join international effort to test drugs for COVID-19

Sweden may reach ‘herd immunity’ in weeks as the country resists total lockdown

First COVID-19-related clinical trial to start in Germany

Fraunhofer SCAI is opening a new knowledge space with information and analysis tools on COVID-19

Research looks at best ways to tackle coronavirus crisis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in